These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 27353661)
1. Disulfiram chelated with copper promotes apoptosis in human breast cancer cells by impairing the mitochondria functions. Yang Y; Zhang K; Wang Y; Li M; Sun X; Liang Z; Wang L; Chen L; Yang H; Zhu L Scanning; 2016 Nov; 38(6):825-836. PubMed ID: 27353661 [TBL] [Abstract][Full Text] [Related]
2. The selective cytotoxicity of DSF-Cu attributes to the biomechanical properties and cytoskeleton rearrangements in the normal and cancerous nasopharyngeal epithelial cells. Yang Y; Li M; Sun X; Zhou C; Wang Y; Wang L; Chen L; Liang Z; Zhu L; Yang H Int J Biochem Cell Biol; 2017 Mar; 84():96-108. PubMed ID: 28111334 [TBL] [Abstract][Full Text] [Related]
3. Disulfiram/copper causes ROS levels alteration, cell cycle inhibition, and apoptosis in acute myeloid leukaemia cell lines with modulation in the expression of related genes. Hassani S; Ghaffari P; Chahardouli B; Alimoghaddam K; Ghavamzadeh A; Alizadeh S; Ghaffari SH Biomed Pharmacother; 2018 Mar; 99():561-569. PubMed ID: 29902866 [TBL] [Abstract][Full Text] [Related]
4. Disulfiram Chelated with Copper Promotes Apoptosis in Osteosarcoma via ROS/Mitochondria Pathway. Ren Y; Lin Y; Chen J; Jin Y Biol Pharm Bull; 2021; 44(10):1557-1564. PubMed ID: 34602566 [TBL] [Abstract][Full Text] [Related]
5. Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer. Kim JY; Cho Y; Oh E; Lee N; An H; Sung D; Cho TM; Seo JH Cancer Lett; 2016 Aug; 379(1):39-48. PubMed ID: 27238567 [TBL] [Abstract][Full Text] [Related]
6. Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways. Xu Y; Zhou Q; Feng X; Dai Y; Jiang Y; Jiang W; Liu X; Xing X; Wang Y; Ni Y; Zheng C Biomed Pharmacother; 2020 Jun; 126():110048. PubMed ID: 32145587 [TBL] [Abstract][Full Text] [Related]
7. The disulfiram/copper complex induces apoptosis and inhibits tumour growth in human osteosarcoma by activating the ROS/JNK signalling pathway. Guo W; Zhang X; Lin L; Wang H; He E; Wang G; Zhao Q J Biochem; 2021 Oct; 170(2):275-287. PubMed ID: 33792698 [TBL] [Abstract][Full Text] [Related]
8. Suppressing autophagy enhances disulfiram/copper-induced apoptosis in non-small cell lung cancer. Wu X; Xue X; Wang L; Wang W; Han J; Sun X; Zhang H; Liu Y; Che X; Yang J; Wu C Eur J Pharmacol; 2018 May; 827():1-12. PubMed ID: 29547841 [TBL] [Abstract][Full Text] [Related]
9. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate. Calderon-Aparicio A; Strasberg-Rieber M; Rieber M Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671 [TBL] [Abstract][Full Text] [Related]
10. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy. Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831 [TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel. Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620 [TBL] [Abstract][Full Text] [Related]
12. Differential Cytotoxicity Mechanisms of Copper Complexed with Disulfiram in Oral Cancer Cells. Chen SY; Chang YL; Liu ST; Chen GS; Lee SP; Huang SM Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918312 [TBL] [Abstract][Full Text] [Related]
13. Disulfiram induces copper-dependent stimulation of reactive oxygen species and activation of the extrinsic apoptotic pathway in melanoma. Morrison BW; Doudican NA; Patel KR; Orlow SJ Melanoma Res; 2010 Feb; 20(1):11-20. PubMed ID: 19966593 [TBL] [Abstract][Full Text] [Related]
14. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death. Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479 [TBL] [Abstract][Full Text] [Related]
15. Process of immunogenic cell death caused by disulfiram as the anti-colorectal cancer candidate. You SY; Rui W; Chen ST; Chen HC; Liu XW; Huang J; Chen HY Biochem Biophys Res Commun; 2019 Jun; 513(4):891-897. PubMed ID: 31003768 [TBL] [Abstract][Full Text] [Related]
16. Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Chen D; Cui QC; Yang H; Dou QP Cancer Res; 2006 Nov; 66(21):10425-33. PubMed ID: 17079463 [TBL] [Abstract][Full Text] [Related]
17. Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer. Allensworth JL; Evans MK; Bertucci F; Aldrich AJ; Festa RA; Finetti P; Ueno NT; Safi R; McDonnell DP; Thiele DJ; Van Laere S; Devi GR Mol Oncol; 2015 Jun; 9(6):1155-68. PubMed ID: 25769405 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation. Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281 [TBL] [Abstract][Full Text] [Related]
19. Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram. Sun T; Yang W; Toprani SM; Guo W; He L; DeLeo AB; Ferrone S; Zhang G; Wang E; Lin Z; Hu P; Wang X Cell Commun Signal; 2020 Mar; 18(1):36. PubMed ID: 32138738 [TBL] [Abstract][Full Text] [Related]
20. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines. Yang Z; Guo F; Albers AE; Sehouli J; Kaufmann AM Biomed Pharmacother; 2019 May; 113():108727. PubMed ID: 30870721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]